Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tempest Therapeutics, Inc.TPST · Entity 7734 | Corporate Controller | March 31, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tempest Therapeutics, Inc.
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.64 · Expires 2036-03-30 | Direct | 22,000 |
Reported balance
After 2026-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 22,000 · Balance 22,000 F1: This option shall vest with respect to 25% of the total number of shares underlying the option on March 31, 2027 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest with respect to 25% of the total number of shares underlying the option on March 31, 2027 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2026 Filed Apr 2, 2026 21:00 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantEmployee Stock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001947673-26-000002 · form4-04022026_050423.xml · derivative · entry 1 Trojanowski Justin · CIK 0001947673 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2036-03-30 F1 · derivative.exercise_date: This option shall vest with respect to 25% of the total number of shares underlying the option on March 31, 2027 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:00 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001415889-25-000808 · form4-01062025_050118.xml · derivative · entry 1 Trojanowski Justin · CIK 0001947673 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: These stock options vest in a series of 48 equal monthly installments measured from January 2, 2025, subject to the Reporting Person's continued service. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:15 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | PurchaseCommon Stock | 7,500 | $2.16 | $16,200.00 |
DisclosureSEC source: 0001415889-24-018866 · form4-07022024_040706.xml · nonDerivative · entry 1 Trojanowski Justin · CIK 0001947673 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,168 F1 · balance_after: Includes 14,668 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:39 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantEmployee Stock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $4.66 | $0.00 |
DisclosureSEC source: 0001209191-24-001036 · doc4.xml · derivative · entry 1 Trojanowski Justin · CIK 0001947673 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Stock · 26,500 shares Expires 2034-01-02 F1 · derivative.exercise_date: These stock options vest in a series of 48 equal monthly installments measured from January 3, 2024, subject to the Reporting Person's continued service. Read SEC document |
| October 11, 2023 Filed Oct 13, 2023 20:39 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantEmployee Stock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $9.77 | $0.00 |
DisclosureSEC source: 0001209191-23-052782 · doc4.xml · derivative · entry 1 Trojanowski Justin · CIK 0001947673 · Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2033-10-10 F1 · derivative.exercise_date: 25% of the award shall vest on October 11, 2024 and the remainder of the award shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:57 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantEmployee Stock Option (right to buy) · Derivative | 20,300 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001209191-23-002141 · doc4.xml · derivative · entry 1 Trojanowski Justin · CIK 0001947673 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,300 Underlying: Common Stock · 20,300 shares Expires 2033-01-02 F1 · derivative.exercise_date: These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 12:01 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantEmployee Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001209191-22-052025 · doc4.xml · derivative · entry 1 Trojanowski Justin · CIK 0001947673 · Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2032-10-02 F1 · derivative.exercise_date: The shares underlying the option will vest in 48 equal monthly installments commencing on November 3, 2022, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.